Australia's most trusted
source of pharma news
Wednesday, 19 November 2025
Posted 19 November 2025 PM
This year the AFR Fast 100 list included an Australian pharma, which has seen success filling a gap in the market.
Reach Pharmaceuticals, which became eligible for the list just this year as it passed the five-year milestone, landed the 95th place on the list with a compound annual growth rate of 27.18 per cent over the past two years. To be eligible, companies must have earned more than $5 million in revenue in financial year 2025, and at least $10,000 in 2023.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.